As of November 6, 2026, Bright Minds Biosciences Inc. is a publicly traded company (Nasdaq: DRUG). The largest holder reporting an active stake on Schedule 13D is Ian McDonald, the executive officer and a director, at 13.7%. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13D/A, July 2, 2026).
Is this your company?
About to sign with, pay or invest in Bright Minds Biosciences Inc.? See the free Snapshot first.
Free to see. No signup.
Is Bright Minds Biosciences Inc. a real, registered company?
- Bright Minds Biosciences Inc. files with the SEC under CIK 1827401 (its SEC filings).
- Its shares are listed under the ticker DRUG on Nasdaq (SEC company record).
- Incorporated in A1; business address in Chicago, Illinois, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under BRIGHT MINDS BIOSCIENCES INC. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Cormorant Asset Management, LP (filed 2026-08-14).
Who are Bright Minds Biosciences Inc.'s owners and officers?
Bright Minds Biosciences Inc.: business address in Chicago, Illinois; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-08-14).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2024-11-19)
- : Executive Officer, Director (Form D, 2024-11-19)
- : Executive Officer (Form D, 2024-11-19)
- : Director (Form D, 2024-11-19)
- : Director (Form D, 2024-11-19)
- : Director (Form D, 2024-11-19)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Cormorant Asset Management, LP | 9.17% |
| Schedule 13G/A, 2026-08-12 | Adage Capital Management, L.P. | 3.41% |
| Schedule 13D/A, 2026-07-02 | Ian Mcdonald | 13.7% |
| Schedule 13G/A, 2026-05-15 | Janus Henderson Group PLC | 13.1% |
| Schedule 13G/A, 2026-05-15 | Janus Henderson Group PLC | 13.1% |
| Schedule 13G, 2026-05-15 | Vestal Point Capital, LP | 5% |
| Schedule 13G/A, 2026-05-12 | Vivo Opportunity Fund Holdings, L.P. | 5.2% |
| Schedule 13G/A, 2026-04-30 | Cormorant Asset Management, LP | 9.71% |
| Schedule 13G/A, 2026-02-17 | Commodore Capital LP | 0.3% |
| Schedule 13G/A, 2026-02-17 | Perceptive Advisors LLC | 4.6% |
| Schedule 13G/A, 2026-02-17 | Janus Henderson Group PLC | 14.9% |
| Schedule 13G/A, 2026-02-06 | Cormorant Asset Management, LP | 10.88% |
Questions about who owns Bright Minds Biosciences Inc.
Who owns Bright Minds Biosciences Inc.?
On this page, 5 holders' latest ownership filings report 5% or more of Bright Minds Biosciences Inc.: Ian Mcdonald (13.7%, Schedule 13D/A, filed 2026-07-02), Janus Henderson Group PLC (13.1%, Schedule 13G/A, filed 2026-05-15), Cormorant Asset Management, LP (9.17%, Schedule 13G/A, filed 2026-08-14), Vivo Opportunity Fund Holdings, L.P. (5.2%, Schedule 13G/A, filed 2026-05-12) and Vestal Point Capital, LP (5%, Schedule 13G, filed 2026-05-15).
Who are the largest shareholders of Bright Minds Biosciences Inc.?
By the share each holder's latest filing reports, the largest holders of Bright Minds Biosciences Inc. on this page are Ian Mcdonald (13.7%), Janus Henderson Group PLC (13.1%) and Cormorant Asset Management, LP (9.17%).
When did Ian Mcdonald buy into Bright Minds Biosciences Inc.?
The filings give report dates, not purchase dates. The earliest filing from Ian Mcdonald on this page is the Schedule 13D/A, filed 2026-07-02, reporting 13.7%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Bright Minds Biosciences Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Bright Minds Biosciences Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Bright Minds Biosciences Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
17 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Bright Minds Biosciences Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- Bihua Chen: 950,000 shares (21.0% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2026-04-30).
- Cormorant Global Healthcare Master Fund, LP: 950,000 shares (21.0% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2026-04-30).
- Cormorant Asset Management, LP: 950,000 shares (21.0% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2026-04-30).
Shares outstanding: 4,524,087 as of 2024-09-30, from the company's latest SEC cover page.
How much has Bright Minds Biosciences Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2024-11-19 | $34.60M | $34.60M |
| Form D, 2024-10-22 | $0 | $12K |
| Form D, 2024-05-03 | $0 | $54K |
Keep reading
More on Bright Minds Biosciences Inc. and the records around it.
Bright Minds Biosciences Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
Companies that share a holder
- Sio Capital Management, LLC also filed stake reports on 9 other companies: Enveric Biosciences, Inc. (Nov 2026), Adagio Medical Holdings, Inc. (Jul 2026), PMV Pharmaceuticals, Inc. (Jul 2026)
- Cormorant Asset Management, LP also filed stake reports on 17 other companies: Corbus Pharmaceuticals Holdings, Inc. (Nov 2026), Adlai Nortye Ltd. (Aug 2026), BioAge Labs, Inc. (Aug 2026)
- Vivo Opportunity Fund Holdings, L.P. also filed stake reports on 20 other companies: ArriVent BioPharma, Inc. (Oct 2026), Clene Inc. (Aug 2026), Compass Therapeutics, Inc. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/bright-minds-biosciences